Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | F13A1 | P00488 | 1/20 | 0.60 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | NLN | Q9BYT8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20854816 | 0.98 | HDAC8 (0.67) | HDAC8KDM4EF13A1SLC7A5MMP2 | |
| SCHEMBL29220965 | 0.94 | HDAC8 (0.59) | HDAC8KDM4EF13A1SLC7A5 | |
| SCHEMBL28260724 | 0.94 | HDAC8 (0.59) | HDAC8KDM4EF13A1SLC7A5 | |
| SCHEMBL3806501 | 0.89 | CA2 (0.66) | HDAC8 | |
| SCHEMBL3806503 | 0.89 | CA2 (0.66) | HDAC8 | |
| SCHEMBL7559848 | 0.89 | HDAC8 (0.64) | HDAC8KDM4ESLC7A5 | |
| SCHEMBL24276974 | 0.87 | HDAC8 (0.57) | HDAC8KDM4EF13A1NLN | |
| SCHEMBL7377691 | 0.87 | SLC7A5 (0.57) | HDAC8SLC7A5MMP2 | |
| Hydrochloric Acid SCHEMBL6299983 | 0.87 | SLC7A5 (0.57) | HDAC8SLC7A5MMP2 | |
| SCHEMBL24276971 | 0.87 | HDAC8 (0.57) | HDAC8KDM4EF13A1NLN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781166-B2 | Biocompositions for 3D printing | 3D-BIOMATERIALS, LLC (US) | 2020-09-22 | — | — | US | disclosed |
| US-20190194123-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | 3D - BIOMATERIALS, LLC | 2019-06-27 | — | — | US | disclosed |
| WO-2019067599-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | NOVOSET, LLC (US) | 2019-04-04 | — | — | WO | disclosed |
| US-20190100489-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | 3D - BIOMATERIALS, LLC | 2019-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194123-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | HTR3D, ILK, ITGB3 | HDAC8 4056/4885KDM4E 2486/4885F13A1 281/4885 |
| US-20190100489-A1 | BIOCOMPOSITIONS FOR 3D PRINTING | HTR3D, ILK, ITGB3 | HDAC8 4056/4885KDM4E 2486/4885F13A1 281/4885 |
| US-10781166-B2 | Biocompositions for 3D printing | HTR3D, ILK, ITGB3 | HDAC8 4056/4885KDM4E 2486/4885F13A1 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.